logo
Plus   Neg
Share
Email

Stock Alert: NeuroMetrix Up 34%

Shares of NeuroMetrix, Inc. (NURO) are trading up nearly 34% on Wednesday morning on no stock-specific news.

NURO is currently trading at $1.55, up $0.39 or 33.62%, on the Nasdaq.

Founded in 1996 as a spinoff from the Harvard-MIT Division of Health Sciences and Technology, NeuroMetrix is a commercial stage, bioelectrical and digital medicine company that addresses chronic health conditions including chronic pain and diabetes.

NeuroMetrix's lead product is Quell, an over-the-counter wearable therapeutic device for chronic pain. The company also markets DPNCheck, a rapid point-of-care test for diabetic neuropathy.

Meanwhile, most of the stocks on Wall Street are down on Wednesday, reflecting the continued negative impact of coronavirus pandemic on the global economy.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Apotex Corp. recalled all lots of type 2 diabetes medication Metformin hydrochloride in the form of oral film-coated tablets for the potential presence of nitrosamine impurity, N-Nitrosodimethylamine (NDMA), above levels of the Acceptable Daily Intake Limit (ADI), the U.S. Food and Drug Administration or FDA said in a statement. Groupe Renault plans to cut about 14,600 jobs across the world and lower its production capacity. The plan includes almost 4,600 jobs reduction in France, through voluntary retirement and retraining. Amazon said it will convert 125,000 of the 175,000 temporary workers it hired in March amid the coronavirus pandemic, to permanent full-time employees in June. The e-commerce giant had hired the temporary employees in March to meet strong consumer demand amid the lockdown. The job openings were in Amazon's fulfillment centers and its delivery network.
RELATED NEWS
Follow RTT